Insights

Information for biotech ventures.
Leveraging Dormant Data in Biotechnology
Posted by Osvaldo D. Rivera, PhD | July 6, 2024 | Business, Informatics

The past decade has witnessed a dramatic reduction in the cost of high-throughput technologies, making data generation more accessible than ever. For instance, the cost of sequencing a human genome has plummeted from approximately $100 million in the early 2000s to less than $1,000 today. This cost reduction has enabled widespread adoption of genomic sequencing...

How to establish a biotech business entity in Puerto Rico to commercialize academic research
Posted by Osvaldo D. Rivera, PhD | December 27, 2023 | Business

Puerto Rico has been recently designated as one of the 31 Tech Hubs in the United States, formally pronounced for the advancement of biotechnology, biopharmaceuticals and biomanufacturing. In Puerto Rico, academics are the class of investigators that are most commonly engaged in the exploration of intricate biological mechanisms and are immersed in the pursuit of...

How Artificial Intelligence is transforming biotechnology
Posted by OZCOGPT | November 17, 2023 | Business

Biotechnology is the field of science that applies biological systems and processes to create products and services that benefit human health, agriculture, environment, and industry. Biotechnology has been advancing rapidly in recent years, thanks to the availability of large amounts of data, powerful computational tools, and innovative techniques. However, biotechnology also faces many challenges, such...

Encoding therapies: RNA-based drugs reshaping healthcare
Posted by Osvaldo D. Rivera, PhD | January 3, 2023 | Healthcare, Therapeutics

RNA-based therapeutic drugs have been recently advancing clinical trials and into the healthcare industry. RNA, or ribonucleic acid, is a fundamental biomolecule essential for the expression of genes encoded in the genome. In the recent years, RNA-based drugs have gained considerable attention because when introduced into cells it is possible to direct them to produce...

2020 A Pivotal Year for Life Science in Philadelphia
Posted by Osvaldo D. Rivera, PhD | February 7, 2021 | Business

An ‘unprecedented’ year for biotechnology in Philadelphia. The State of Pennsylvania saw a total of $1.47 billion in venture capital investment and growth in 2020, a decline from 2019's whooping $2.9 billion inflow, but still an impressive number in a year where everything was 'unprecedented'. Within the Life Science and Biotechnology sector, three companies originating...